|
+ |
|
→ |
|
+ | UDP |
|
+ |
|
→ |
|
+ | UDP |
* Produces type 1 chain linkage in glycolipids and core-3 O-glycans, but not N-linked glycoproteins.
* May be an important enzyme forming CA19-9 in colon cancer. Beyond serving as a biomarker, CA19-9 also promotes pancreatitis and pancreatic cancer (in mice).
* B3GalT5 efficiently transfers Gal to the GlcNAc of the glycolipid Lc3Cer and to the terminal GalNAc residue of the globoside Gb4.
* It may thus contribute to the formation of CA 19-9, SSEA-3 and elongated core-3 O-glycans.
* Expression is restricted to the colorectum, small intestine, stomach, and pancreas.
ER | Cis- | Medial- | Trans- | TGN |
---|---|---|---|---|
B3GALT5/hsa-miR-1199-5p |
---|
miRNA Target | Site Type | Pos. | Context Score | Frac. | Wt. Context | Frac. | Conserved | Quality |
---|---|---|---|---|---|---|---|---|
5'...AUGUAUAAAUUA
GGCUCAGA
... 3' GACGCGCCGGGC CCGAGUC C |
8mer | 733-740 | -0.25 | 94.0 | -0.25 | 96.0 | noncon | |
5'...GGAUGCAAACGA
GGCUCAGA
... 3' GACGCGCCGGGC CCGAGUC C |
8mer | 2254-2261 | -0.107 | 79.0 | -0.107 | 86.0 | noncon | |
5'...AGGAAAGCCAAA
GCUCAGA
A... 3' GACGCGCCGGGCC CGAGUC C |
7mer-A1 | 7822-7828 | -0.046 | 63.0 | -0.046 | 74.0 | noncon | |
5'...GACUUCCCCGGG
GGCUCAGA
... 3' GACGCGCCGGGC CCGAGUC C |
8mer | 8250-8257 | -0.03 | 56.0 | -0.03 | 69.0 | noncon | |
5'...AAGGACCCCUCG
GGCUCAGA
... 3' GACGCGCCGGGC CCGAGUC C |
8mer | 1017-1024 | -0.03 | 56.0 | -0.03 | 69.0 | noncon | |
5'...GUGAGGUCUGUU
GGCUCAG
G... 3' GACGCGCCGGGC CCGAGUC C |
7mer-m8 | 10721-10727 | -0.02 | 46.0 | -0.02 | 62.0 | noncon |